The OIG work plan item on SNF drugs during Part A stays, project OAS-25-09-057, is an audit of whether skilled nursing facilities met their duty to pay for the drugs of Part D enrollees during covered Part A stays. It follows a 2024 OIG audit that estimated up to $465.1 million in improper Part D payments for those drugs. Facilities should expect the review to rest on records: physician orders, medication administration records, pharmacy delivery records and stay dates.
What is on the OIG Work Plan for SNF drugs?
The OIG Work Plan is the HHS Office of Inspector General's public list of audits and evaluations it has planned or has under way. On April 15, 2025, it added SNFs' Financial Responsibility for Drugs for Medicare Part D Enrollees in Part A SNF Stays, project number OAS-25-09-057.
The entry states two aims. First, to determine whether SNFs complied with federal requirements for assuming financial responsibility for drugs used by Part D enrollees during Part A stays. Second, where residents or their families supplied drugs that Part D paid for, to examine why the SNFs obtained the drugs from them.
That second aim is new. The earlier audit looked at what Part D plans paid. This one looks at what facilities did.
What did the 2024 OIG audit find?
The earlier audit, A-09-21-03008, was issued in October 2024 and covered 2018 through 2020. It reviewed a stratified random sample of 215 items. A PDE, or prescription drug event, is the record a Part D plan submits to CMS for each paid prescription.
Its main findings:
- For all 215 sample items, Part D improperly allowed PDEs for drugs dispensed during Part A stays.
- For 89 items, SNF medical records confirmed the drugs were administered during the stay.
- For 136 items, there was no documentation to show whether the drugs from the pharmacy on the PDE were administered.
- The OIG estimated up to $465.1 million in Part D total cost, including about $245.4 million for drugs the records showed were administered during Part A stays.
- Enrollees themselves paid an estimated $21 million out of pocket for these drugs.
The full report breaks the administered drugs down by pharmacy type.
| Pharmacy type | Sample items | Items where records showed administration | Part D cost for administered drugs |
|---|---|---|---|
| Long-term care | 50 | 36 | $50,278 |
| Specialty | 65 | 36 | $358,932 |
| Retail and other | 100 | 17 | $132,442 |
| Total | 215 | 89 | $541,652 |
The specialty row is the one to study. Specialty drugs are fewer in number but far higher in cost. The report found that for 34 of the 36 specialty items where administration was confirmed, the drugs had been provided to the SNF by the enrollee or the family. In one example, a facility accepted an admission only after the family agreed to supply a lung cancer drug, and Part D paid $15,494 for one 30-tablet fill.
What could your building recover?
Two numbers, instant estimate. No email needed.
Why did Part D keep paying?
The report gives the plan sponsors' explanation. They said they had no reliable, timely source of Part A stay dates. CMS's quarterly report to sponsors did not include specific admission and discharge dates, so sponsors had to contact facilities, and some sponsors said facilities did not always cooperate.
The OIG made five recommendations to CMS, and CMS concurred with all five. One asked CMS to instruct SNFs to cooperate with plan sponsors in identifying and preventing improper payments; the OIG lists it as implemented on June 23, 2025. CMS published SNF fast facts on May 15, 2025, pointing facilities to its updated SNF billing reference. Recommendations to identify similar noncompliance before, during and after the audit period were still listed as open.
What records would an auditor look at?
We cannot predict how the OIG will run OAS-25-09-057. The 2024 audit does show what the OIG treated as evidence. Its auditors reviewed SNF documentation such as physician orders, medication administration records (MARs) and pharmacy shipping and delivery records. A MAR is the chart where nurses record each dose given.
| Record | What it proves | Common gap |
|---|---|---|
| Census with Part A start and end dates | Which days the facility was responsible | Payer changes entered late or not sent to the pharmacy |
| Physician orders | The drug was ordered during the stay | Orders that do not match what the pharmacy dispensed |
| MAR | The drug was administered, and when | Doses given from a supply that is not on any facility invoice |
| Pharmacy delivery records | Who supplied the drug | Deliveries from a pharmacy the facility has no contract with |
| Pharmacy invoices | The facility paid for it | Part A residents with no drug charges for days at a time |
| Admission notes and agreements | How the drug was sourced | Notes that a family will "bring in" a medication |
The gap that matters most is the third row. A drug on the MAR with no matching facility invoice is the pattern the 2024 audit found in its specialty examples.
What should a facility do now?
- Reconcile one recent quarter. For each Part A resident, compare MAR entries to pharmacy invoice lines for the same dates.
- Find doses with no facility cost. Any administered drug that no facility invoice covers needs an explanation in writing.
- Ask the pharmacy for its Part D claims for Part A residents. Request claims with dates of service inside a Part A stay, and how it reversed or rebilled them.
- Review admissions practice for high-cost drugs. Look for any expectation that residents or families supply drugs during a Part A stay. Our article on family-supplied medications during a Part A stay covers why this matters.
- Set a process for plan sponsor requests. Name an owner, a response time and the records you will send, such as stay dates.
- Keep the evidence together. Census extract, invoice, MAR and resolution, filed by month.
- Talk to counsel about what you find. If a review shows past improper Part D claims, decisions about next steps are legal ones.
Our Part A drug compliance checklist turns these into a monthly routine.
Free · 48 hours · no integration
Get a free 48-hour pharmacy audit
- Send three files: invoices, census, contract
- See overbilling and Part A exposure, line by line
- BAA signed before any data moves
Who carries the most risk?
Exposure scales with Part A volume and with high-cost admissions. A short-stay or rehab-heavy facility has more Part A days and more admissions from hospitals with specialty drugs already in place. An independent nursing home often has one person handling census, billing and pharmacy reconciliation, which is where lags start.
For the underlying payment rule, see who pays for drugs during a Part A stay.
Free report · New York editionThe Part A Pharmacy Report 202620 pages built from public CMS data: Part A days, drug cost estimates, the 20-point invoice checklist.Get the report
This article is general information, not legal advice. It describes public OIG and CMS documents and does not predict the outcome of any audit.
Frequently asked questions
Is the OIG auditing my facility?
The Work Plan describes a project, not a list of facilities. The 2024 audit drew a statistical sample from claims data and then requested records from the facilities involved. Whether or not your facility is sampled, the same records would answer the question the OIG is asking.
What does "financial responsibility" for drugs mean in a Part A stay?
It means the facility pays for the drugs it ordinarily furnishes to a resident during a covered Part A stay, because those drugs are included in its Medicare per diem. CMS's benefit policy manual says the supplier must look to the facility, not the patient, for payment.
What is the difference between the 2024 audit and the new project?
The 2024 audit, A-09-21-03008, examined Part D payments and recommended actions for CMS and plan sponsors. The new project, OAS-25-09-057, examines whether SNFs met their own obligations, including why some obtained drugs from residents or families.
When will the OIG publish the new report?
The OIG had not published a final report for OAS-25-09-057 when we checked in November 2026. Its Work Plan page lists the project as active. Check the OIG site for updates.
Get the 48-hour first look
Send three months of invoices, your census and your pharmacy services agreement. Within 48 hours we show you where payer status on the invoice does not match the census, and which Part A days have no facility drug cost at all. Request the free 48-hour audit, or estimate your exposure with the savings calculator.